A Severe Case of Recalcitrant Pompholyx
Related Experiment Video
Updated: Apr 14, 2026
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Jeewanjit Gill1, Melanie Pratt2
1University of Ottawa, Ottawa, ON, Canada jgill089@uottawa.ca.
Background:
Pompholyx is an inflammatory vesiculobullous skin disease of the hands and feet belonging to the spectrum of eczema.
Objective:
To report a severe case of pompholyx, its clinical presentation, and its management.
Methods:
A medical chart review was conducted on a patient with this condition.
Results:
The patient was patch tested according to the North American Contact Dermatitis Group (NACDG) Standard Screening Series, and results were negative. In the past, she was treated with corticosteroid creams as well as narrow band ultraviolet B (UVB), and Psoralen ultraviolet A (PUVA) therapies, and none were beneficial. When the frequency of the episodes increased, methotrexate was introduced but failed to control the condition. Next, mycophenolate mofetil was started and gradually increased to 3.5 g daily along with a separate trial of radiotherapy with marked success.
Conclusion:
Pompholyx can be challenging to manage, and treatment can involve an assortment of therapies over a prolonged period of time.
Related Concept Videos
01:26Methods of Documentation II: POMR
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...